28.70
price down icon2.08%   -0.61
after-market アフターアワーズ: 28.70
loading

Mbx Biosciences Inc (MBX) 最新ニュース

pulisher
01:46 AM

UBS initiates coverage on MBX Biosciences stock with Buy rating - Investing.com

01:46 AM
pulisher
Jan 05, 2026

MBX Biosciences (NASDAQ:MBX) Trading Down 8.4%Here's Why - MarketBeat

Jan 05, 2026
pulisher
Jan 04, 2026

Power Grid Corporation of India Limited Forms Bullish Flag Upside AheadGlobal Trade Effects & Free Trading Psychology Coaching - earlytimes.in

Jan 04, 2026
pulisher
Dec 29, 2025

Commit To Purchase Mbx Biosciences At $20, Earn 25% Using Options - Nasdaq

Dec 29, 2025
pulisher
Dec 26, 2025

MBX Biosciences (NASDAQ:MBX) Stock Price Down 5.8%Here's What Happened - MarketBeat

Dec 26, 2025
pulisher
Dec 24, 2025

MBX Biosciences initiated with a sell at Goldman Sachs - MSN

Dec 24, 2025
pulisher
Dec 23, 2025

MBX Biosciences (NASDAQ:MBX) Reaches New 12-Month HighStill a Buy? - MarketBeat

Dec 23, 2025
pulisher
Dec 22, 2025

Mbx Biosciences stock hits all-time high of 34.85 USD By Investing.com - Investing.com Nigeria

Dec 22, 2025
pulisher
Dec 22, 2025

MBX Biosciences (NASDAQ:MBX) Stock Price Up 10.8%Still a Buy? - MarketBeat

Dec 22, 2025
pulisher
Dec 22, 2025

Mbx Biosciences stock hits all-time high of 34.85 USD - Investing.com

Dec 22, 2025
pulisher
Dec 22, 2025

MBX Biosciences price target raised to $50 from $45 at Stifel - MSN

Dec 22, 2025
pulisher
Dec 22, 2025

Take Profit: Will MBX Biosciences Inc stock keep outperforming rivalsJuly 2025 Pullbacks & Capital Efficiency Focused Ideas - moha.gov.vn

Dec 22, 2025
pulisher
Dec 21, 2025

MBX Biosciences, Inc.(NasdaqGS:MBX) added to S&P Pharmaceuticals Select Industry Index - marketscreener.com

Dec 21, 2025
pulisher
Dec 21, 2025

MBX Biosciences, Inc.(NasdaqGS: MBX) added to NASDAQ Biotechnology Index - marketscreener.com

Dec 21, 2025
pulisher
Dec 21, 2025

Dip Buying: Will MBX Biosciences Inc stock keep outperforming rivalsJuly 2025 Intraday Action & Stock Portfolio Risk Control - moha.gov.vn

Dec 21, 2025
pulisher
Dec 21, 2025

MBX Biosciences (NASDAQ:MBX) Upgraded at Wall Street Zen - MarketBeat

Dec 21, 2025
pulisher
Dec 19, 2025

How sustainable is MBX Biosciences Inc. stock dividend payoutPortfolio Profit Report & Safe Entry Point Alerts - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Stifel maintains MBX Biosciences (MBX) buy recommendation - MSN

Dec 19, 2025
pulisher
Dec 19, 2025

Will MBX Biosciences Inc. stock attract ESG investorsWeekly Profit Summary & Detailed Earnings Play Alerts - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

MBX Biosciences stock price target raised to $50 by Stifel on strong trial data By Investing.com - Investing.com Nigeria

Dec 19, 2025
pulisher
Dec 19, 2025

Stifel Maintains MBX Biosciences (MBX) Buy Recommendation - Nasdaq

Dec 19, 2025
pulisher
Dec 19, 2025

MBX Biosciences stock price target raised to $50 by Stifel on strong trial data - Investing.com South Africa

Dec 19, 2025
pulisher
Dec 19, 2025

Is MBX Biosciences Inc. stock positioned well for digital economyJuly 2025 Trends & AI Driven Stock Reports - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Aug Technicals: Will MBX Biosciences Inc. stock attract ESG investorsMarket Activity Recap & AI Enhanced Trading Alerts - Улправда

Dec 19, 2025
pulisher
Dec 18, 2025

Is MBX Biosciences Inc. stock undervalued vs historical averagesJuly 2025 Sector Moves & High Accuracy Trade Signal Alerts - Улправда

Dec 18, 2025
pulisher
Dec 16, 2025

S P Trends: What catalysts could drive MBX Biosciences Inc stock higherEarnings Growth Summary & Free Weekly Watchlist of Top Performers - moha.gov.vn

Dec 16, 2025
pulisher
Dec 16, 2025

MBX Biosciences (MBX) faces platform validation challenge as near-term hypoglycemia data catalyst in Q2 2026 may lack differentiation - MSN

Dec 16, 2025
pulisher
Dec 16, 2025

MBX Biosciences, Inc. (NASDAQ:MBX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Dec 16, 2025
pulisher
Dec 15, 2025

MBX Biosciences (MBX) Faces Platform Validation Challenge as Near-Term Hypoglycemia Data Catalyst in Q2 2026 May Lack Differentiation - Finviz

Dec 15, 2025
pulisher
Dec 15, 2025

MBX Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13 - The Manila Times

Dec 15, 2025
pulisher
Dec 15, 2025

20 Stocks That Will Double in 2026 - Insider Monkey

Dec 15, 2025
pulisher
Dec 13, 2025

EcoR1 Capital LLC Lowers Holdings in MBX Biosciences, Inc. $MBX - MarketBeat

Dec 13, 2025
pulisher
Dec 13, 2025

MBX Biosciences (NASDAQ:MBX) Lowered to Sell Rating by Wall Street Zen - MarketBeat

Dec 13, 2025
pulisher
Dec 11, 2025

Walleye Capital LLC Increases Stock Holdings in MBX Biosciences, Inc. $MBX - MarketBeat

Dec 11, 2025
pulisher
Dec 10, 2025

MBX Biosciences: Testing 2026 May Deliver Another Year Of Share Price Gains - Seeking Alpha

Dec 10, 2025
pulisher
Dec 10, 2025

MBX Biosciences, Inc. $MBX Stake Increased by Stempoint Capital LP - MarketBeat

Dec 10, 2025
pulisher
Dec 09, 2025

MBX Biosciences (NASDAQ:MBX) Shares Down 5.6%Should You Sell? - MarketBeat

Dec 09, 2025
pulisher
Dec 09, 2025

Resolute Capital Asset Partners LLC Acquires New Position in MBX Biosciences, Inc. $MBX - MarketBeat

Dec 09, 2025
pulisher
Dec 08, 2025

Certain Common Stock of MBX Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 9-DEC-2025. - marketscreener.com

Dec 08, 2025
pulisher
Dec 08, 2025

Certain Stock Options of MBX Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 9-DEC-2025. - marketscreener.com

Dec 08, 2025
pulisher
Dec 06, 2025

Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA), MBX Biosciences, Inc. (MBX) and Praxis Precision Medicines (PRAX) - The Globe and Mail

Dec 06, 2025
pulisher
Dec 05, 2025

MBX Biosciences (NASDAQ:MBX) Shares Gap DownHere's What Happened - MarketBeat

Dec 05, 2025
pulisher
Dec 05, 2025

Goldman Sachs initiates coverage of MBX Biosciences (MBX) with sell recommendation - MSN

Dec 05, 2025
pulisher
Dec 04, 2025

Goldman Sachs Initiates Coverage of MBX Biosciences (MBX) with Sell Recommendation - Nasdaq

Dec 04, 2025
pulisher
Dec 04, 2025

MBX Biosciences (MBX) Is Down 9.7% After Goldman Sell Call and MPM ExitWhat's Changed - Yahoo Finance

Dec 04, 2025
pulisher
Dec 04, 2025

Goldman Sachs initiates MBX Biosciences stock with Sell rating on platform concerns - Investing.com Nigeria

Dec 04, 2025
$40.65
price up icon 2.52%
$33.10
price up icon 4.09%
$106.66
price up icon 4.78%
$98.09
price up icon 1.28%
biotechnology ONC
$320.35
price up icon 0.02%
$175.07
price down icon 0.07%
大文字化:     |  ボリューム (24 時間):